Skip to main content
Retour
Watch Compare

Polaryx Therapeutics, Inc.

Qualité des données : 83%
PLYX
NASDAQ Manufacturing Chemicals
6,47 €
▲ 0,30 € (4,86%)
6 months return
—
Momentum
Neutral
ROE
-196,82%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-196,82%
En dessous de la moyenne du secteur (-54,49%)
ROIC-135,35%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio8,55
Interest CoverageN/A

Valorisation

PE (TTM)
-29,52
En dessous de la moyenne du secteur (-1,50)
P/B Ratio58,11
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -3,94 M

Price History

Tendances Financières

Objectif de Cours des Analystes

1 analyste
Strong Buy
+54.6%
upside to target
Actuel
6,47 €
Consensus Target
10,00 €
10,00 €
Bas
10,00 €
Haut
Prévisions
BPA Prévisionnel
-0,28 €
CA Est.
0,0

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,03 € · Rev Est: 0,0
Q42025 Q1 '26 Q2 '26
Reported -0,16 € — —
Estimate -0,02 € -0,03 € -0,03 €
Surprise -700,00% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -196,82% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -8,99 M
ROE -196,82% ROA -173,79%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3,94 M
ROIC -135,35% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 8,55
Debt / Equity N/A Current Ratio 8,55
Interest Coverage N/A Asset Turnover N/A
Working Capital 4,57 M Tangible Book Value 4,57 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -29,52 · EV/EBITDA: N/A
P/E Ratio -29,52 Forward P/E N/A
P/B Ratio 58,11 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1,49%
Market Cap 265,27 M Enterprise Value 260,12 M

Per Share

EPS: -0,20 · FCF/Share: -0,09
EPS (Diluted TTM) -0,20 Revenue / Share N/A
FCF / Share -0,09 OCF / Share -0,09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 43,90% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 43,90%
SBC-Adj. FCF -8,67 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -8,99 M
EPS (Diluted) -0,20
Gross Profit —
Operating Income -7,82 M
EBITDA —
R&D Expenses 6,27 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 5,17 M
Total Liabilities 605 000,0
Shareholders' Equity 4,57 M
Total Debt —
Cash & Equivalents 5,14 M
Current Assets 5,17 M
Current Liabilities 605 000,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -29,5 -1,5
P/B 58,1 1,6
ROE % -196,8 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3